(TSX:PRN),(NASDAQ:PROF), TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private placement of common shares to Canadian investors (the “Offering”). Pursuant to the Offering, the Company issued an aggregate of 921,428 common shares at a price of […]

(TSX-V:PVF-UN),(TSX-V:PVF-UN),(TSX-V:PVF-U),(TSX-V:PVF.U),(TSX-V:PVF-PU), TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership”) (TSX VENTURE: PVF) announced today that it has received approval from the TSX Venture Exchange (the “Exchange”) to renew its normal course issuer bids (collectively, the “Bids”) to purchase: (i) up to 35,256,779 of its nonâ€voting equity limited partnership units (the

Profound Medical Corp. Announces Closing of Private Placement GlobeNewswire December 30, 2025 TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that it has completed its previously announced private placement of common shares to Canadian investors (the “Offering”). Pursuant to the Offering, the Company

Partners Value Investments L.P. Announces Renewal of Normal Course Issuer Bids GlobeNewswire December 30, 2025 TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership”) (TSX VENTURE: PVF) announced today that it has received approval from the TSX Venture Exchange (the “Exchange”) to renew its normal course issuer bids (collectively, the “Bids”)

Saia to Announce Fourth Quarter 2025 Results on February 10, 2026 GlobeNewswire December 30, 2025 JOHNS CREEK, Ga., Dec. 30, 2025 (GLOBE NEWSWIRE) — Saia, Inc. (Nasdaq: SAIA), a leading transportation provider offering national less-than-truckload (LTL), non-asset truckload, expedited and logistics services, announced that it will release its quarterly financial results before the market opens

(NASDAQ:RARE), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE GlobeNewswire December 30, 2025 NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle

(OtherOTC:EVLI),(OTC US:EVLI), LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Everlert, Inc. (OTC: EVLI) today announced the completion of its previously disclosed strategic merger with Zanieri, an Italian luxury apparel and knitwear company, pursuant to which Zanieri has acquired control of Everlert and contributed its operating business into the public company through a completed change

Everlert (EVLI) Completes Strategic Merger With Italian Luxury Apparel Company Zanieri Merger creates a public platform for international expansion of Zanieri's premium apparel operations GlobeNewswire December 30, 2025 LOS ANGELES, Dec. 30, 2025 (GLOBE NEWSWIRE) — Everlert, Inc. (OTC: EVLI) today announced the completion of its previously disclosed strategic merger with Zanieri, an Italian luxury

(NASDAQ:INO), NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inovio and certain of its officers and/or directors have